NeRRe Therapeutics Company
NeRRe Therapeutics Ltd. operates as a biotechnology company that develops clinical and pre-clinical neurokinin receptor antagonists. The company was founded in 2012 and is based in Stevenage, United Kingdom.
Headquarters:
Stevenage, Herefordshire, United Kingdom
Number Of Exists:
Series B
Total Funding:
$47M
Founded Date:
2012
Employee Number:
11-50
Investment Stage:
N/A
Last Funding Type:
Series B
Investor Type:
Company
Investors Number:
7
Technology:
Anti-infective Drugs
Funding Status:
Early Stage Venture
Estimated Revenue:
$1M to $10M
Industry:
PharmTech